Small area estimation of human papillomavirus vaccination coverage among school-age children in Alabama counties

Public Health. 2019 Dec:177:120-127. doi: 10.1016/j.puhe.2019.08.006. Epub 2019 Sep 24.

Abstract

Objectives: This study estimated county-level human papillomavirus (HPV) vaccination initiation rates in Alabama and determined whether disparities existed between counties in the Mississippi Delta region (MDR) and Appalachian region (AR).

Study design: This study used an observational cross-sectional design.

Methods: We used small area estimation methodology to estimate rates of medical provider-verified HPV vaccine initiation among school-age children in Alabama. Data for the study were retrieved from the 2015 National Immunization Survey (n = 22,205) and the US Census Bureau.

Results: The predictive model results showed that older age (odds ratio [OR] = 1.22, 95% confidence interval [CI] = 1.16, 1.29) was positively associated with vaccination initiation and black (OR = 0.79, 95% CI = 0.71, 0.87), white (OR = 0.56, 95% CI = 0.52, 0.60), and 'other' race/ethnicities (OR = 0.78, 95% CI = 0.70, 0.86), compared with Hispanics, and was negatively associated with vaccination initiation. The median (x̃)-modeled HPV vaccination initiation rate for all Alabama counties was 50.83% (interquartile range = 5.00%). Modeled HPV vaccination initiation rates were lowest in AR counties (x̃ = 49.81%), followed by counties not in the AR or MDR (x̃ = 53.26%) and MDR counties (x̃ = 54.90%).

Conclusions: Culturally sensitive school-based HPV vaccine delivery programs are needed for children living in AR counties in Alabama.

Keywords: Adolescents; Alabama; Appalachia; HPV vaccination; Small area estimation.

Publication types

  • Observational Study

MeSH terms

  • Adolescent
  • Alabama
  • Child
  • Cross-Sectional Studies
  • Female
  • Health Care Surveys
  • Humans
  • Male
  • Papillomavirus Vaccines / administration & dosage*
  • Small-Area Analysis
  • Vaccination Coverage / statistics & numerical data*
  • Young Adult

Substances

  • Papillomavirus Vaccines